The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

20 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia.EBI
Sanford Burnham Prebys Medical Discovery Institute
Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators.EBI
Sanford Burnham Prebys Medical Discovery Institute
Discovery of small molecule antagonists of chemokine receptor CXCR6 that arrest tumor growth in SK-HEP-1 mouse xenografts as a model of hepatocellular carcinoma.EBI
Sanford Burnham Prebys Medical Discovery Institute
1,2,3-Triazoles as Amide Bioisosteres: Discovery of a New Class of Potent HIV-1 Vif Antagonists.EBI
Sanford Burnham Prebys Medical Discovery Institute
Discovery of ?-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators.EBI
Sanford Burnham Prebys Medical Discovery Institute
Discovery of Imidazo[1,2-EBI
Sanford Burnham Prebys Medical Discovery Institute
Discovery of 5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide (SBI-425), a potent and orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitor.EBI
Sanford Burnham Prebys Medical Discovery Institute
Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors.EBI
Sanford Burnham Prebys Medical Discovery Institute
Potent and Selective EphA4 Agonists for the Treatment of ALS.BDB
Sanford Burnham Prebys Medical Discovery Institute